back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-09 18:26 Tx date 2026-03-08 |
$ONCY
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-120,000 vol |
1,464,200 | |
| Filed 2026-02-13 09:50 Tx date 2026-02-12 |
$ONCY
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,033
+12,132 vol $0.83 each |
168,201 | |
| Filed 2025-12-19 18:19 Tx date 2025-12-15 |
$ONCY
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$247,500
+250,000 vol $0.99 each |
1,584,200 | |
| Filed 2025-12-11 18:17 Tx date 2025-12-10 |
$ONCY
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-55,000 vol |
1,334,200 | |
| Filed 2025-08-22 18:50 Tx date 2025-08-22 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-70,000 vol |
1,389,200 | |
| Filed 2025-08-22 18:49 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$615,600
+570,000 vol $1.08 each |
1,459,200 | |
| Filed 2025-08-18 18:54 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+7,967 vol |
156,069 | |
| Filed 2025-08-18 18:53 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-7,967 vol |
114,617 | |
| Filed 2025-07-18 09:00 Tx date 2025-07-17 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,050
+15,000 vol $1.27 each |
148,102 | |
| Filed 2025-01-29 13:31 Tx date 2025-01-29 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+93,436 vol |
133,102 | |
| Filed 2025-01-29 12:43 Tx date 2025-01-29 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+93,436 vol |
133,102 | |
| Filed 2025-01-29 12:43 Tx date 2025-01-29 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+93,436 vol |
||
| Filed 2025-01-29 12:42 Tx date 2025-01-29 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-147,760 vol |
122,584 | |
| Filed 2024-12-20 17:20 Tx date 2024-12-18 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+213,010 vol |
270,344 | |
| Filed 2024-12-20 17:19 Tx date 2024-12-18 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$275,268
+243,600 vol $1.13 each |
889,200 | |
| Filed 2024-12-12 09:57 Tx date 2024-12-09 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+20,700 vol |
39,666 | |
| Filed 2024-12-12 09:56 Tx date 2024-12-09 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-20,700 vol |
57,334 | |
| Filed 2024-12-12 09:55 Tx date 2024-12-11 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-100,000 vol |
645,600 | |
| Filed 2024-11-28 10:18 Tx date 2024-11-27 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+7,966 vol |
18,966 | |
| Filed 2024-11-28 10:17 Tx date 2024-11-27 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-7,966 vol |
78,034 |